Researchers at Harvard University’s Dana-Farber Cancer Institute have found a cannabis flavonoid to have “significant therapy potential” for treating pancreatic cancer. In studies, the flavonoid derivative – FBL-03G – killed tumor cells in 70 percent of mice with pancreatic cancer.

Wilfred Ngwa, PhD, an assistant professor at Harvard and one of the study’s researchers said that the “most significant conclusion” of the study is “that tumor-targeted delivery of flavonoids, derived from cannabis, enabled both local and metastatic tumor cell kill.” He added that this could “significantly” increase survival rates for the disease.

See the original article at Ganjapreneur